ARCHIVES

FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002